The new new contracts, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.
Weekly Digest
New new contracts, summarized for you
Straight to Inbox
No login, no app to check — it comes to you
Contract Trends
See who's moving and how much in your market
No credit card required Weekly contract digest
AstraZeneca Partners with Virginia for Significant Multi-Billion Dollar Manufacturing Investment.
Jul 22, 2025•11 months ago
Contract Type
partnership
Cambridge
Description
AstraZeneca has selected Virginia for its largest single facility investment, part of a plan to invest $50 billion in the U.S. by 2030. The project is expected to create hundreds of skilled jobs and strengthen the domestic supply chain for pharmaceuticals.
Company Information
Company
British biopharma company
Location
Cambridge, Massachusetts, United States
About
A British biopharmaceutical company focused on developing new therapies and treatments for various diseases. The company is known for its expertise in drug development and innovative approaches to healthcare. It aims to address unmet medical needs through advanced biopharmaceutical solutions. Details on its specific operations or pipeline are not provided in the current context.